Navigation Links
Breast Cancer in younger women can be detected at an early stage by mammograms

The January issue of the medical journal Cancer reported a study by the researchers of the Health Sciences Center in Denver, which showed that regular mammography screening for women in their 40s leads to diagnosis of breast cancer at an earlier stage. This could facilitate the use of more effective and less radical treatment options.//

Sandra Buseman, MD, lead author of the study and colleagues found that nearly 25% of all breast cancer deaths occur in women who were diagnosed between ages 40 and 49. Buseman claimed that while breast cancer incidence has increased over the past decade, breast cancer deaths had decreased. She attributed this to the widespread adoption of mammography screening, in addition to improvements made in therapy. However, she also added that the debate on effectiveness of screening mammography in reducing breast carcinoma mortality for women who are 40 to 49 years of age is still on.

Buseman and her colleagues, in the latest study, looked at 247 women diagnosed with breast cancer between the ages of 42 and 49. While 105 of the women had received a mammogram in the two years before being diagnosed, 142 had not undergone screening. They found that those women who had been screened were 44% less likely to be diagnosed with a later stage of breast cancer compared with women who had not received regular mammograms. 58% of cancers were detected by mammography alone and these cancers were more likely to be diagnosed at an early stage. They also observed that there were no significant differences in regard to treatment in the screened and unscreened groups due to the fact that stage II breast cancers, although classified as 'late stage', are treated similarly to early stage cancers. However, Buseman concluded that the study did not address potentially harmful consequences of mammography among women in their 40s. She said that the test is less accurate in younger women, and in some cases, noninvasive (in situ) cancers might be t reated more aggressively than is necessary.

Breast cancer, which is the second leading cause of cancer death in women, would account for about 39,800 deaths in the US, according to an American Cancer Society estimate. The society also estimated that in 2003 about 211,300 new cases of invasive breast cancer (stages I to IV) will be diagnosed among women in America. Carcinoma in situ (CIS) will account for an additional 55,700 new cases this year. However, the brighter side of these studies indicate that the breast cancer incidence rate has been steadily falling from 4% per year during 1980s to less than 1% per year in recent years.


'"/>




Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Breast cancer treatment to be determined by gene test
3. Breast Feeding prevents obesity later on in life
4. Breast milk is essential
5. Breast Cancer Surgery Causes Psychological problems
6. Breast cancer evidence
7. Letrozole Beats Tamoxifen in Breast Cancer Therapy
8. Breast screening among diabetic women
9. Breast feeding can alter hormones
10. Diet, Sunlight connected to Breast Cancer Risk
11. Additional Radiotheraphy for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... ... containerization, today announced an exhibitor sponsorship at MobileIron Live! 2017 in ... new technologies for an immersive, educational approach to helping organizations maximize the benefits ...
(Date:4/26/2017)... ... April 26, 2017 , ... Jump Technologies, ... today announced it has completed a round of funding to accelerate its growth ... partners. Black Granite Capital is a growth equity firm focused on investments in ...
(Date:4/26/2017)... ... April 26, 2017 , ... Datos Health , ... partnership with Med-e-Mass , the largest Electronic Medical Records (EMR) provider in South ... care plan incentives to a patient’s remote health progress, empowering the patient to take ...
(Date:4/26/2017)... ... , ... RawTrition now brings you BioEnergy which is a powder capsule whole ... , RawTrition is taking nutrients to the next level! The superfoods in RawTrition's ... form (unlike the synthetically made options that are on the market). , Founder of ...
(Date:4/25/2017)... ... April 25, 2017 , ... Bellus Medical, a leader ... in a new class of photodynamic cosmetics (PDC). , Allumera® is the first ... outward signs of aging, and minimize the appearance of pores – all with ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Eyevensys, ... the first non-viral gene expression technology that enables the ... eye to address a wide range of ophthalmic diseases, ... and Healthcare products Regulatory Agency (MHRA) to advance its ... ...
(Date:4/19/2017)... The Mobile X-Ray product segment is the most ... the forecast period Mobile X-Ray segment is the ... X-Ray devices market, which is estimated to be valued at ... CAGR of 7% over the forecast period. Mobile X-Ray segment ... US$ 100 Mn in 2017 over 2016. The segment,s revenue ...
(Date:4/19/2017)... PUNE, India , April 19, 2017 ... Type and Application, Forecast to 2022 report has covered and ... provides statistics and information on market size, shares and growth ... with major drivers, challenges and opportunities in the global market. ... Browse 152 Tables and ...
Breaking Medicine Technology: